Aarti Drugs Share Price
Aarti Drugs Share Price Today
As of 5 Jul 2026, Aarti Drugs share price is ₹386.60. The stock opened at ₹385.95, compared to its previous close of ₹384.45. During today's trading session, Aarti Drugs share price moved in the range of ₹383.75 to ₹394.85, with an average price of ₹389.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹318.95 and a high of ₹564.05. On the performance front, Aarti Drugs share price has declined by 5.93% over the last six months and is down 20.11% on a year-on-year basis.
Aarti Drugs Returns Calculator
Aarti Drugs Shareholder Returns
Aarti Drugs Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Aarti Drugs Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2,387.03 | ₹2,528.58 | ₹2,716.05 | ₹2,488.65 |
| Other Income | ₹16.36 | ₹4.03 | ₹2.19 | ₹11.32 |
| Total Revenue | ₹2,403.39 | ₹2,532.61 | ₹2,718.25 | ₹2,499.96 |
| Total Expenses | ₹2,191.62 | ₹2,297.08 | ₹2,494.07 | ₹2,230.01 |
| Profit Before Tax | ₹211.77 | ₹235.53 | ₹224.18 | ₹269.96 |
| Tax | ₹43.67 | ₹63.94 | ₹57.82 | ₹64.96 |
| Profit After Tax | ₹168.10 | ₹171.59 | ₹166.36 | ₹205.00 |
| EPS - Basic | ₹18.42 | ₹18.65 | ₹17.97 | ₹22.12 |
| EPS - Diluted | ₹18.42 | ₹18.65 | ₹17.97 | ₹22.12 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹211.77 | ₹235.53 | ₹224.18 | ₹269.96 |
| Income before WC changes | ₹296.11 | ₹318.54 | ₹309.33 | ₹341.14 |
| Change in Assets | ₹47.31 | ₹195.32 | -₹88.60 | -₹304.50 |
| Change in Liabilities | -₹43.73 | -₹92.53 | -₹27.74 | ₹117.15 |
| Change in WC | ₹3.59 | ₹102.79 | -₹116.34 | -₹187.35 |
| Cash flow from Operations | ₹244.58 | ₹358.92 | ₹133.32 | ₹70.41 |
| Cash flow from Investing | -₹164.63 | -₹223.65 | -₹163.97 | -₹149.64 |
| Cash flow from Financing | -₹82.12 | -₹136.03 | ₹16.54 | ₹92.03 |
| Total Cash Flow | -₹2.17 | -₹0.76 | -₹14.11 | ₹12.80 |
| Cash (Start of the year) | ₹6.74 | ₹7.50 | ₹21.61 | ₹8.81 |
| Cash (End of the year) | ₹4.58 | ₹6.74 | ₹7.50 | ₹21.61 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,236.32 | ₹1,111.64 | ₹929.05 | ₹814.59 |
| Current Assets | ₹1,338.36 | ₹1,320.72 | ₹1,492.35 | ₹1,393.37 |
| Total Assets | ₹2,574.68 | ₹2,432.36 | ₹2,421.40 | ₹2,207.96 |
| Current Liabilities | ₹836.97 | ₹795.54 | ₹932.98 | ₹940.06 |
| Net Current Asset | ₹501.39 | ₹525.18 | ₹559.37 | ₹453.31 |
| Non-Current Liabilities | ₹368.37 | ₹354.86 | ₹295.75 | ₹231.60 |
| Equity Capital | ₹1,369.34 | ₹1,281.95 | ₹1,192.67 | ₹1,036.30 |
| Total Equity & Liabilities | ₹2,574.68 | ₹2,432.36 | ₹2,421.40 | ₹2,207.96 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2,173.65 | ₹2,266.91 | ₹2,497.97 | ₹2,251.17 |
| Other Income | ₹13.57 | ₹4.18 | ₹2.23 | ₹4.77 |
| Total Revenue | ₹2,187.23 | ₹2,271.09 | ₹2,500.20 | ₹2,255.95 |
| Total Expenses | ₹1,988.47 | ₹2,078.61 | ₹2,295.39 | ₹2,000.45 |
| Profit Before Tax | ₹198.75 | ₹192.48 | ₹204.81 | ₹255.50 |
| Tax | ₹41.44 | ₹50.60 | ₹52.00 | ₹60.50 |
| Profit After Tax | ₹157.31 | ₹141.88 | ₹152.81 | ₹195.00 |
| EPS - Basic | ₹17.24 | ₹15.43 | ₹16.50 | ₹21.04 |
| EPS - Diluted | ₹17.24 | ₹15.43 | ₹16.50 | ₹21.04 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹198.75 | ₹192.48 | ₹204.81 | ₹255.50 |
| Income before WC changes | ₹268.84 | ₹270.17 | ₹283.24 | ₹322.26 |
| Change in Assets | ₹9.12 | ₹168.24 | -₹76.31 | -₹315.17 |
| Change in Liabilities | -₹5.92 | -₹50.08 | ₹9.60 | ₹112.91 |
| Change in WC | ₹3.19 | ₹118.17 | -₹66.71 | -₹202.27 |
| Cash flow from Operations | ₹220.08 | ₹337.10 | ₹161.70 | ₹39.90 |
| Cash flow from Investing | -₹134.92 | -₹187.09 | -₹131.14 | -₹125.36 |
| Cash flow from Financing | -₹84.60 | -₹148.81 | -₹30.54 | ₹84.11 |
| Total Cash Flow | ₹0.56 | ₹1.20 | ₹0.03 | -₹1.35 |
| Cash (Start of the year) | ₹2.72 | ₹1.52 | ₹1.49 | ₹2.84 |
| Cash (End of the year) | ₹3.28 | ₹2.72 | ₹1.52 | ₹1.49 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,092.23 | ₹990.60 | ₹845.96 | ₹761.33 |
| Current Assets | ₹1,180.56 | ₹1,181.02 | ₹1,349.53 | ₹1,273.19 |
| Total Assets | ₹2,272.79 | ₹2,171.62 | ₹2,195.50 | ₹2,034.52 |
| Current Liabilities | ₹705.79 | ₹684.60 | ₹847.39 | ₹854.68 |
| Net Current Asset | ₹474.77 | ₹496.42 | ₹502.14 | ₹418.52 |
| Non-Current Liabilities | ₹315.65 | ₹311.81 | ₹233.80 | ₹207.67 |
| Equity Capital | ₹1,251.35 | ₹1,175.21 | ₹1,114.30 | ₹972.17 |
| Total Equity & Liabilities | ₹2,272.79 | ₹2,171.62 | ₹2,195.50 | ₹2,034.52 |
About Aarti Drugs
Aarti Drugs Limited is an India-based company, which is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates in the pharmaceuticals segment. Its geographical segments include Out of India and India. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.
Aarti Drugs Financial Highlights
- Revenue: Aarti Drugs reported revenue of ₹2,567.70 crore in FY26 vs ₹2,403.39 crore in FY25. It showed an increase of 6.84% on a yearly basis.
- Operating Profit: Aarti Drugs reported an operating profit of ₹210.90 crore in FY26 vs ₹211.77 crore in FY25. It showed a decrease of 0.41% on a year-on-year basis.
- Net Profit: Aarti Drugs reported a net profit of ₹194.94 crore in FY26 vs ₹168.10 crore in FY25. It showed an increase of 15.97% on a yearly basis.
Aarti Drugs Quarterly Result Highlights
- Aarti Drugs reported revenue of ₹721.06 crore in Mar 2026, compared with ₹602.94 crore in Dec 2025, representing an increase of 19.59% on a quarter-on-quarter (QoQ) basis.
- Aarti Drugs reported an operating profit of ₹70.36 crore in Mar 2026, compared with ₹29.02 crore in Dec 2025, representing an increase of 142.45% on a quarter-on-quarter (QoQ) basis.
- Aarti Drugs reported a profit of ₹55.26 crore in Mar 2026, compared with ₹40.55 crore in Dec 2025, reflecting an increase of 36.28% on a QoQ basis.
- The earnings per share (EPS) of Aarti Drugs stood at ₹18.42 during Mar 2026.
Similar Stocks
FAQs on Aarti Drugs Share Price
What is Aarti Drugs share price today?
Aarti Drugs share price is ₹386.60 as on 03 Jul, 2026, 15:57 IST.
How has the Aarti Drugs share price performed in the past?
In the last 1 year, Aarti Drugs delivered a return of -20.11%. The Aarti Drugs share price hit a high of ₹564.05 and low of ₹318.95.
How much is the Mutual Fund shareholding in Aarti Drugs shares?
The Mutual Fund Shareholding in Aarti Drugs was 10.14% at the end of Mar 2026.
What is the the 52-week high and low of Aarti Drugs shares ?
The 52-week high and low of Aarti Drugs share is ₹564.05 and ₹318.95 as of 03 Jul, 2026.
What is the market cap of Aarti Drugs?
The market capitalisation of Aarti Drugs is ₹3,502.49 Crores as on 03 Jul, 2026.
What are the stock symbols of Aarti Drugs?
The stock symbol of Aarti Drugs is AARTIDRUGS on the NSE, 524348 on the BSE, and the ISIN is INE767A01016.
What was yesterday's closing price of Aarti Drugs shares ?
Aarti Drugs shares closed yesterday at ₹384.45 on NSE & ₹383.75 on BSE
How to buy Aarti Drugs shares?
To buy Aarti Drugs shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Aarti Drugs shares on Holidays?
No, shares of Aarti Drugs or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Aarti Drugs shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Aarti Drugs?
The PE and PB ratio of Aarti Drugs is 17.97 and 2.26 respectively, as on 03 Jul, 2026, 15:57 IST.